(S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NP (NNS cytokines)) (CC and) (NP (NNS antibodies)))) (ADVP (FW in) (FW vivo)))) (. .)))
(S1 (S (S (NP (NP (NN Age-)) (CC and) (NP (JJ gender-matched) (JJ normal) (NN B6) (NNS mice))) (VP (VBD received) (NP (NP (DT every) (JJ other) (NN day) (ADJP (ADJP (JJ intraperitoneal)) (PRN (-LRB- -LRB-) (NP (NN ip)) (-RRB- -RRB-))) (NNS injections)) (PP (IN of) (NP (NP (NNS PBS)) (, ,) (NP (NP (CD 1.5) (NN mug) (CD rmIL-4)) (, ,) (NP (NP (ADJP (CD 50) (NN mug)) (NN anti-IL-4) (NN mAb)) (PRN (-LRB- -LRB-) (NP (CD 11B11) (CC or) (CD MAB404)) (-RRB- -RRB-)))) (, ,) (CC or) (NP (NP (DT a) (NN mixture)) (PP (IN of) (NP (NP (NP (NP (CD 1.5) (NN mug) (CD rmIL-4)) (CC plus) (NP (ADJP (CD 50) (NN mug)) (NN anti-IL-4) (NN mAb))) (PRN (-LRB- -LRB-) (NP (CD 11B11) (CC or) (CD MAB404)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 7) (NN d))))))))))) (. .)))
(S1 (S (S (ADVP (RB Thereafter)) (, ,) (NP (NP (NP (NN spleen)) (CC and) (NP (NN lymph) (NN node))) (NNS cells)) (VP (VBD were) (VP (VBN analyzed) (PP (IN by) (NP (NN flow) (NN cytometry))) (PP (IN for) (NP (NP (NN CD3)) (, ,) (NP (NN CD4)) (, ,) (CC and) (NP (NN CD25)) (NP (NN expression))))))) (. .)))
(S1 (S (S (NP (DT The) (JJ anti-mouse) (NN IL-4) (NN mAb) (CD MAB404)) (VP (VBD was) (VP (VBN obtained) (PP (IN from) (NP (NN R) (NN &) (NN D) (NNS Systems)))))) (, ,) (S (NP (DT the) (JJ second) (JJ anti-mouse) (NN IL-4) (NN mAb) (NN 11B11)) (VP (VBD was) (VP (VBN purchased) (PP (IN from) (NP (NN eBioscience)))))) (. .)))
